Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11274130
HV1 modulators and uses
granted -
US 11273431
Biologically applicable water-soluble heterogeneous catalysts for para-hydrogen induced polarization
granted -
US 11273167
Compositions and methods for modulating ABHD2 activity
granted -
US 11261471
Methods and compositions for making vault particles in yeast
granted -
US 11261432
Method and composition for inducing human pluripotent stem cells
granted -
US 11261231
Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors
granted -
US 11260070
Methods of treating feline coronavirus infections
granted -
US 11260058
Compositions and method of treating cancer
granted -
US 11255865
Immunoassay for human erythroferrone
granted -
US 11254640
N-substituted indoles and other heterocycles for treating brain disorders
granted -
US 11253522
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 11253483
Protease assisted native-protein delivery approach (PANDA)
granted -
US 11253546
Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20
granted -
US 11248213
Platform for generating safe cell therapeutics
granted -
US 11246961
Engineered scaffolds for vascularized tissue repair
granted -
US 11247985
Phenyl indole allosteric inhibitors of P97 ATPase
granted -
US 11247974
Small molecules that enable cartilage rejuvenation
granted -
US 11246940
Peptides whose uptake in cells is controllable
granted -
US 11242543
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 11242510
Mammalian cells devoid of lactate dehydrogenase activity
granted -
US 11241483
Methods of treating mild brain injury
granted -
US 11241380
Porous photonic crystals for drug delivery to the eye
granted -
US 11241394
Treating vasculature related diseases or disorders using nanoparticles
granted -
US 11234992
Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides
granted